Michigan Center for Diabetes Translational Research (MCDTR)

The MCDTR is a multidisciplinary unit of the University of Michigan funded by the National Institute of Diabetes and Digestive and Kidney Diseases/National Institutes of Health. The MCDTR is one of seven NIH Centers funded to focus on type 2 translational research in diabetes (e.g. bedside to practice and the community). Its goal is to facilitate innovative adaptations of evidence-based approaches to prevent and treat diabetes that can be disseminated and sustained in clinical practice and in settings outside the traditional academic research environment. The mission of the MCDTR is to establish, promote, and enhance multidisciplinary collaboration among researchers directed at the prevention and control of diabetes, its complications, and comorbidities, by providing access to specialized expertise and resources. Our research investigators are our most important resource.

The MCDTR focuses on research to better translate interventions that have clearly demonstrated efficacy into real-world populations, health care settings, and communities. The MCDTR helps to ensure that new research findings actually reach the patients and populations for whom they are intended, and that they are implemented correctly. The MCDTR seeks to improve the quality of care by helping patients and clinicians alter behaviors and make more informed choices. By empowering the patient, strengthening the patient-clinician relationship, providing reminders and point-of-care decision support tools, and reorganizing and coordinating systems of care, more effective prevention and treatment of diabetes can be achieved.